Sundowning is the deeply challenging symptom affecting 66% of those living with dementia or Alzheimer's, when anxiety, confusion, and restlessness often increase as daylight fades. For countless families, it becomes the tipping point: an unbearable source of stress and exhaustion that too often forces an early move into residential care. At Glow Therapeutics, we focus on easing these hardest hours, restoring calm and reducing that pressure, so families can stay together at home for longer.
🌱 Seed Round (with EIS Advance Assurance) now open. Enquire here.

Every Founder Edition device has now been claimed and is no longer available to buy. Thank you to the early supporters who made this possible.
Available Now
Glow Therapeutics combines cutting-edge photobiology with deep empathy for the dementia care journey. Our approach is grounded in research, validated by clinicians, and shaped by real families.
Every feature is designed with dignity, comfort, and the caregiver experience in mind.
Helping families stay together longer by reducing the need for institutional care.
Targeting sundowning symptoms when they're most difficult, restoring calm to the hardest hours.
Harmoni connects families and caregivers through the Glow app, providing reassurance around device use, daily routines and the home environment, wherever they may be.
Glow App · Peace of mind
Harmoni is online
Evening programme completed
Home temperature
19°C · Within chosen range
Today's routine
No unusual changes today
Helpful notifications
You choose what matters to you
Concept illustration — features in development
Sundowning affects 10's of millions of families every evening. The need for better solutions is urgent.
People living with dementia globally
A new dementia diagnosis is reported
Experience sundowning symptoms
Annual dementia care costs (latest available figures from 2019)
Caregiver burden
We're launching Harmoni in Q1 2027. Join us as an early supporter, investor, or partner and help bring light to more families living with dementia.